Whitebox Advisors’s Cidara Therapeutics CDTX Stock Holding History

Whitebox Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-125,001	Closed	-$27.6M	–	573
2025 Q4	$27.6M	Buy	+125,001	New	+$20.2M	0.39%	54

Whitebox Advisors's CDTX Position: Q1 2026 in Review

Whitebox Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 125,001 shares — an estimated $27.6M sold.

Whitebox Advisors first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $27.6M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Whitebox Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Whitebox Advisors sold 125,001 Cidara Therapeutics shares in Q1 2026, an estimated $27.6M.
Whitebox Advisors first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Whitebox Advisors's Cidara Therapeutics position peaked at $27.6M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Whitebox Advisors's 13F filing for Q1 2026, filed 15 May 2026.